Related Experiment Videos
Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors
1Department of Obstetrics and Gynecology, School of Medicine, Osaka University, Japan.
Abstract:
The protooncogene c-kit encodes a transmembrane receptor-type tyrosine kinase which belongs to the beta-PDGER/CSF-1 receptor tyrosine kinase family. The interaction between c-kit receptor and its corresponding ligand, stem cell factor (SCF), has been suggested to be involved in embryogenesis as well as carcinogenesis via the autocrine/paracrine system. In the present study, cancer cell lines and normal/benign/malignant tissues of the human female genital tract were examined for the expression of both c-kit and SCF by Northern blot and immunohistochemical analyses. Two of 16 cell lines showed mRNA expression of both c-kit and SCF, while 2 and 12 cell lines expressed c-kit and SCF, respectively. In tissues, several cases of malignant tumors, including three cervical cancers, one ovarian cancer, and one ovarian immature teratoma, expressed mRNA of both c-kit and SCF. In normal tissues, squamous epithelium expressed SCF immunohistochemically, while c-kit protein was detected only in melanocytes. Some tissues of malignant tumors, one squamous cell carcinoma of the cervix, two small cell carcinomas of the cervix, two serous adenocarcinomas of the ovary, and two immature teratomas of the ovary, expressed both c-kit and SCF proteins immunohistochemically. It is also notable that c-kit protein was expressed only in malignant germ cells of dysgerminomas, while SCF was expressed in the connective tissues surrounding germ cells. The present study suggests that the c-kit/SCF system may play an important role in the carcinogenesis of the female genital tract.
Insights
The protooncogene c-kit and stem cell factor (SCF) system may drive female genital tract cancers. This study investigated c-kit/SCF expression in normal and cancerous tissues, revealing their potential role in carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Gynecologic Pathology
Background:
- The protooncogene c-kit encodes a receptor tyrosine kinase involved in embryogenesis and carcinogenesis.
- The interaction between c-kit and its ligand, stem cell factor (SCF), suggests a role in autocrine/paracrine signaling pathways.
- Dysregulation of c-kit/SCF signaling is implicated in various cancers.
Purpose of the Study:
- To investigate the expression of c-kit and SCF in human female genital tract cancer cell lines and tissues.
- To determine the potential role of the c-kit/SCF system in the carcinogenesis of the female genital tract.
Main Methods:
- Northern blot analysis to detect mRNA expression of c-kit and SCF.
- Immunohistochemical analysis to detect protein expression of c-kit and SCF in tissues and cell lines.
Main Results:
- c-kit and SCF mRNA were co-expressed in some female genital tract cancer cell lines.
- Malignant tissues, including cervical and ovarian cancers, showed co-expression of c-kit and SCF mRNA.
- Immunohistochemistry revealed co-expression of c-kit and SCF proteins in various malignant tumors, with specific expression patterns in germ cell tumors.
Conclusions:
- The c-kit/SCF system is expressed in the female genital tract and its dysregulation is associated with malignancy.
- The c-kit/SCF signaling pathway may play a significant role in the development and progression of female genital tract cancers.
- Targeting the c-kit/SCF system could be a potential therapeutic strategy for these cancers.